The nation of Zimbabwe has declined a substantial US healthcare agreement valued at 367 million US dollars (£272m) spanning five years because of Washington's demand for sensitive data.
The decision came to light following a official document from December was leaked, which showed Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".
An official spokesman has since clarified that the United States was requesting genetic material for scientific study and profit but was not willing to guarantee the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate process of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had furnished over $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged further negotiations to reach a agreement agreeable to all parties so the country's critical HIV treatment initiative can continue.
Broader Background
This rejection follows a comparable situation in Kenya, where a high court suspended a related health funding agreement following legal challenges were filed about the safety of Kenyans' medical information.
Since resuming office last year, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
USAID had overseen aid for the US government, but Trump argued its spending was "inefficient" and his administration was seeking government-to-government deals to enhance openness and accountability.
As per reports, Sixteen African countries have so far signed similar agreements, representing over $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, without any equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," he stated.
"Put simply, our country would supply the basic resources for medical research without any assurance that the resulting innovations would be accessible to our people should a future disease outbreak arise."
National Interest and Global Health
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining systems already established through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing system created to manage potential global health emergencies.
"This system is intended to ensure that when a nation contributes its samples, the benefits – including vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to create them."
These objections over the US deal "are not meant as hostility towards the US," he added.
"We encourage ongoing dialogue with our US partners on how future co-operation could be structured in a way that respects the independence and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but recommended that talks should continue considering much of the country's HIV programmes depended on external financing.
"If specific concerns arise, including those relating to data governance or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," the group said.
The situation highlights the ongoing challenges between accepting crucial international aid and protecting national sovereignty in an increasingly interconnected world.